Royce & Associates LP reduced its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,050 shares of the medical technology company’s stock after selling 6,150 shares during the period. Royce & Associates LP owned 0.33% of Teleflex worth $30,759,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Meiji Yasuda Asset Management Co Ltd. increased its stake in shares of Teleflex by 49.2% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,940 shares of the medical technology company’s stock valued at $611,000 after buying an additional 970 shares in the last quarter. American Century Companies Inc. boosted its position in Teleflex by 22.8% in the second quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock valued at $174,327,000 after buying an additional 155,863 shares during the last quarter. Victory Capital Management Inc. boosted its position in Teleflex by 21.0% in the second quarter. Victory Capital Management Inc. now owns 7,325 shares of the medical technology company’s stock valued at $1,522,000 after buying an additional 1,269 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in Teleflex by 1.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 126,601 shares of the medical technology company’s stock valued at $26,303,000 after buying an additional 1,416 shares during the last quarter. Finally, GAM Holding AG boosted its position in Teleflex by 64.3% in the second quarter. GAM Holding AG now owns 3,533 shares of the medical technology company’s stock valued at $734,000 after buying an additional 1,383 shares during the last quarter. Hedge funds and other institutional investors own 90.49% of the company’s stock.

Teleflex Incorporated (TFX) opened at 207.01 on Monday. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $217.97. The firm has a market cap of $9.32 billion, a PE ratio of 39.59 and a beta of 1.05. The firm’s 50-day moving average is $210.33 and its 200 day moving average is $199.98.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. During the same period last year, the firm posted $1.89 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, equities analysts forecast that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Friday, August 11th. Teleflex’s payout ratio is 26.00%.

COPYRIGHT VIOLATION NOTICE: “Royce & Associates LP Sells 6,150 Shares of Teleflex Incorporated (TFX)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/28/royce-associates-lp-sells-6150-shares-of-teleflex-incorporated-tfx.html.

Several equities analysts have commented on the stock. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $223.00 target price on the stock in a research note on Wednesday, May 24th. Jefferies Group LLC reissued a “buy” rating and set a $230.00 target price on shares of Teleflex in a research note on Thursday, August 3rd. BidaskClub cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Barclays PLC reissued a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Finally, Needham & Company LLC reissued a “buy” rating and set a $224.00 target price on shares of Teleflex in a research note on Friday, May 5th. One analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company. Teleflex has an average rating of “Buy” and a consensus price target of $228.83.

In other news, Director Gretchen R. Haggerty purchased 1,000 shares of the business’s stock in a transaction dated Wednesday, June 21st. The shares were purchased at an average cost of $203.82 per share, with a total value of $203,820.00. Following the completion of the purchase, the director now owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $208.41, for a total value of $41,682.00. Following the sale, the director now directly owns 8,080 shares in the company, valued at $1,683,952.80. The disclosure for this sale can be found here. Insiders have sold 3,100 shares of company stock worth $637,463 over the last three months. Insiders own 2.39% of the company’s stock.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.